The Global Systemic Scleroderma Treatment Market size was valued at USD 1.4 billion in 2019 and is expected to expand at a compound annual growth rate CAGR of 7% from 2022 to 2028. Systemic neurodermia is an autoimmune disease that affects not only the skin but also internal organs such as the lungs, muscles, blood […]
